Navigation Links
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Date:7/9/2012

SOUTH SAN FRANCISCO, Calif., July 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:   ONXX) today announced that it has appointed John E. Osborn as Senior Vice President, Global Corporate Affairs.  In his role, Mr. Osborn will report to N. Anthony Coles, M.D., President and Chief Executive Officer, and will be responsible for the public and government affairs activities of the company, as well as key stakeholder relationships.

"As a lawyer, policy advocate and former diplomat, John brings a diverse and extensive background to Onyx, with broad experience across the life sciences industry and the U.S. government," said Dr. Coles.  "John is a proven leader and his unique expertise aligns well with our plan for global growth as a multi-product company reaching patients around the world."

Prior to joining Onyx, Mr. Osborn was Executive Vice President, General Counsel and Secretary at Dendreon Corporation.  Previously, he held similar roles at US Oncology, Inc., where he worked on its merger with McKesson, and at Cephalon, Inc., where he managed legal, public and government affairs during a critical growth period.  Mr. Osborn also served with the U.S. Department of State during the George H.W. Bush administration, and in 2008 was confirmed by the Senate as a member of the bipartisan United States Advisory Commission on Public Diplomacy.  He has held faculty appointments at Oxford, Princeton and the University of Washington, served on the board of governors of the East-West Center in Hawaii, and examined the peace process in Northern Ireland as an Eisenhower Fellow.  Early in his career he clerked for Judge Albert V. Bryan of the U.S. Court of Appeals for the Fourth Circuit, and practiced corporate law in Boston for Hale and Dorr (now WilmerHale).  Mr. Osborn received his undergraduate degree in economics and history from the University of Iowa, his law degree from the University of Virginia School of Law, and his master's degree in international public policy from The Johns Hopkins University School of Advanced International Studies.

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer.  The company is focused on developing novel medicines that target key molecular pathways.  For more information about Onyx, visit the company's website at www.onyx.com.

Forward-Looking Statements

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws.  These forward-looking statements include without limitation, statements regarding the progress and results of preclinical and clinical development of carfilzomib.  These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including risks related to the development and commercialization of pharmaceutical products.  Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements.  Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors.  Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release.  Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals to Present at JMP Investor Conference
2. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
3. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
4. Amgen Completes Acquisition of KAI Pharmaceuticals
5. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
7. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
8. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
9. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
10. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
11. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... ... September 01, 2020 , ... Neil Oberfeld ... as Secretary to the Board of Trustees and committee chair of the Governance ... is a Denver-based nonprofit organization that fights for the education, health, and financial ...
(Date:8/31/2020)... ... August 31, 2020 , ... If you live in New York City you will always ... makes sense, it’s the law of supply and demand, but are plastic surgeons in New ... significant percentage of their patients that make the four-hour trip to have expert aesthetic treatments ...
(Date:8/28/2020)... ANGELES (PRWEB) , ... August 28, 2020 , ... ... integrative medicine and aesthetic beauty, bringing a unique perspective and approach. Armed with ... Dr. Rahi ventured out to share her knowledge of the human body with ...
Breaking Medicine Technology:
(Date:9/2/2020)... WASHINGTON, Pa. (PRWEB) , ... September 02, 2020 ... ... development of enterprise software for healthcare payers administering Medicare Advantage and Special Needs ... Duals Online presented by America’s Health Insurance Plans (AHIP). RAM is supporting the ...
(Date:9/1/2020)... ... 01, 2020 , ... Feeding Matters , the first organization in the ... (PFD), is pleased to announce that the U.S. Centers for Disease Control and Prevention ... the next edition of the U.S. International Classification of Diseases (ICD ) on ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) to develop a ... patients who have undergone open heart surgery. , The AGH/CMU team was recently ...
(Date:8/31/2020)... SPRINGS, Miss. (PRWEB) , ... August 31, 2020 ... ... Plus (GCPP) recently donated 1,400 N95 face masks to medical first responders across ... has continued to make donations of personal protective equipment (PPE) medical centers ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... opportunities through high-quality, career-relevant, and affordable online education – is proud to announce ... , Among the first of its kind in the nation, the 60-credit hour ...
Breaking Medicine News(10 mins):